Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 2975
Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report
Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Cosmos IF
- Ulrich's Periodicals Directory
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
- world cat
- journal seek genamics
- j-gate
- esji (eurasian scientific journal index)
Useful Links
Recommended Journals
Related Subjects
Share This Page
Update on prostatic adenocarcinoma
14th Asia Pacific Pathology Congress
Turki Omar Al-Hussain
King Faisal Specialist Hospital and Research Center, KSA
ScientificTracks Abstracts: J Clin Exp Pathol
Abstract
Prostatic adenocarcinma is the second most common malignancy worldwide. There have been new updates on pathology of prostatic adenocarcinoma. Recently, the International Society of Urological Pathology held a consensus conference in 2014 which was published in 2015. This conference predominantly deliberated with definition of various grading patterns of usual prostatic adenocarcinoma, grading of intraductal carcinoma and the new grade groups. Most of these updates were implemented and applied in the new 2016 WHO Classification of Tumors of the Prostate. The presentation will discuss the new update of prostatic adenocarcinoma with focus on grading system.Biography
Turki Omar Al-Hussain has completed his MBBS degree in King Saud University, Riyadh, KSA. He has completed Pathology training at King Faisal Specialist Hospital in 2008 and then he joined the University of North Carolina at Chapel Hill, USA as Renal Pathology Fellow (2009-2010). In 2011, he has completed another year of Fellowship in Genitourinary Pathology at John Hopkins Hospital, Baltimore, USA. Currently, he is a Consultant Pathologist specializing in Nephropathology and Urologic Pathology. He is also the Director of Pathology Residency Training Program and has published 27 papers in peer reviewed journals, and has been invited as speaker in several conferences locally and internationally.
